(Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has entered into a securities purchase agreement for a private placement of approximately $85 million in upfront gross ...
Early flight validation shows more than 30% increase in flight range, unlocking new operational possibilities and commercial ramp-up for drone operators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results